MarginsXMarginsX
Home › Markets › Health Care › DAVI

Davion Healthcare Plc (DAVI)

DAVI trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.02
+2.00% on the day
Market cap
$25.5M
Nano cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerDAVI on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIreland
IPO yearNot reported by the screener
SEC CIK0002039072
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inCyprus

Financials

No annual revenue in SEC XBRL data for this filer.

Warning signs

Cash runway
39.3 months
$1K cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed April 30, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-04-30
Cash and burn$1K cash; operating cash flow -$89 a quarter.Report 2025-12-31
Shares outstanding25,000,000 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-08-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-$911K-$357$1KNo debt tagsNeeds four quarters20-F 2026-04-30

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-10-20
Latest annual report
FORM 20-F FOR DEC 2025
20-F2026-04-30
Latest quarterly / interim
CURRENT REPORT
6-K2026-11-16

Source: SEC EDGAR submissions feed, 34 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-37.1%
1 monthNot enough price history
3 monthsNot enough price history
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-91.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PLRZPolyrizon Ltd.$10.70-2.37%$26.0M
NSPRInspireMD Inc.$0.6000-6.85%$28.1M
BEATHeartbeam Inc.$0.3590-9.23%$22.7M
XTNTXtant Medical Holdings Inc.$0.2098-22.78%$29.4M
NEPHNephros Inc.$3.00-1.64%$32.6M
TELATELA Bio Inc.$0.7616-7.13%$34.4M
MODDModular Medical Inc.$1.91-3.05%$18.1M
PMIPicard Medical Inc.$7.24+0.14%$17.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier